JAIME OUGEL: Open Payments
NPI 1346476611 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 26 payments from 7 companies in 2025. Trend: 2023 $818 · 2024 $102 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $224 |
| Vanda Pharmaceuticals Inc. | 5 | $94 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: VIVITROL, ARISTADA, FANAPT, UZEDY, Auvelity, VRAYLAR, REXULTI, INVEGA SUSTENNA.
Industry payments across LA — which companies pay providers there.
